Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02960594
Title hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Inovio Pharmaceuticals
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.